¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"SureStep Pro Low Glucose InVt"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® glucose ÇÑ±Û Æ÷µµ´ç
¼³¸í   
  C6H12O6ÀÇ ±¸Á¶¸¦ °¡Áø ¹°Áú. Åº¼öÈ­¹° ´ë»çÀÇ ¸¶Áö¸· »ê¹°À̸砻ý¸íüÀÇ ÁÖ¿¡³ÊÁö¿øÀÌ´Ù. Æ¯È÷ ³úÀÇ °æ¿ì¿¡´Â ´Ù¸¥ °ÍÀ» ¿µ¾çºÐÀ¸·Î »ç¿ëÇÏÁö ¾Ê°í ´ÜÁö Æ÷µµ´ç¸¸À» ¿¡³ÊÁö¿øÀ¸·Î ÀÌ¿ëÇÑ´Ù. ¼¼Æ÷¿¡¼­ »ç¿ëÇÏ°í ³²Àº ¿©ºÐÀÇ Æ÷µµ´çÀº ±Û¸®ÄÚ°ÕÀ¸·Î ¹Ù²î¾î °£°ú ±ÙÀ°¿¡ ÀúÀåµÇ°í ±× ÀÌ»óÀº Áö¹æÁ¶Á÷¿¡¼­ ÁöÁú·Î º¯È¯µÇ¾î¼­ ÀúÀåµÈ´Ù.
¿µ¹® glucose tolerance test ÇÑ±Û Æ÷µµ´ç°ßµõ°Ë»ç
¼³¸í   
  Æ÷µµ´ç°ßµõ °Ë»ç¶õ ´ç´¢º´ÀÇ Áø´Ü¿¡ »ç¿ëµÇ´Â °Ë»ç·Î ´çÀ» Ã¼³»¿¡ Åõ¿©ÇÏ°í ½Ã°£ º°·Î Ç÷¾×À» Ã¤ÃëÇÏ¿© Ç÷´çÀÇ ³óµµ¸¦ Àç¾î¼­ °íÇ÷´ç ¿©ºÎ¸¦ Á¶»çÇϴ °Ë»çÀÌ´Ù. ÁַΠ°æ±¸Æ÷µµ´ç°ßµõ°Ë»ç(oral glucose tolerance test)¸¦ ¸¹ÀÌ Çϴµ¥ À̰ÍÀº 10~16½Ã°£ÀÇ ±Ý½Ä ÈÄ¿¡ Ã¤Ç÷À» Çѹø Çѵڿ¡ µµ´ç 75gÀ» 250~300mLÀÇ ¹°¿¡ ³ì¿© 5ºÐ¿¡ °ÉÃļ­ ¸¶½Ã°Ô ÇÏ°í ¸Å½Ã°£ º°·Î Ã¤Ç÷À» ÇÏ¿© Ç÷´çÀÇ ³óµµ¸¦ Ã½Å©ÇÑ´Ù. °øº¹½Ã¿¡ Á¤¸Æ¿¡¼­ Ã¤Ç÷ÇÏ¿© ÃøÁ¤ÇÑ Ç÷´çÀÌ 140mg/dLÀÌ»óÀ̰ųª Æ÷µµ´ç°ßµõ °Ë»ç 2½Ã°£ÈÄÀÇ Ç÷´çÀÌ 200mg/dLÀÌ»óÀÏ °æ¿ì¿¡´Â ´ç´¢º´À¸·Î Áø´ÜÀ» ÇÑ´Ù. ±×·¯³ª ÀÌ °Ë»ç¸¦ ½Ç½ÃÇÒ °æ¿ì¿¡ ÁÖÀÇÇØ¾ß ÇÒ Á¡Àº °Ë»çÀü 3Àϰ£ ÇÏ·ç¿¡ 150gÀÌ»óÀǠź¼öÈ­¹°À» ¼·ÃëÇØ¾ß ÇѴٴ °Í°ú °Ë»çµµÁß¿¡ ¿îµ¿, Èí¿¬ µîÀ» ÇÏÁö ¾Ê¾Æ¾ß ÇѴٴ °ÍÀÌ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood glucose
    Ç÷´ç
  • blood glucose monitoring
    Ç÷´ç°¨½Ã
  • glucose
    Æ÷µµ´ç, ´ç±Û·çÄÚ¿À½º
  • glucose dehydrogenase
    Æ÷µµ´çÅ»¼ö¼ÒÈ¿¼Ò
  • glucose fermenter
    Æ÷µµ´ç¹ßÈ¿Åë
  • glucose fluctuation
    Æ÷µµ´çº¯µ¿
  • glucose intolerance
    Æ÷µµ´ç¸ø°ßµõ(Áõ), Æ÷µµ´çºÒ³»¼º
  • glucose lactate cycle
    Æ÷µµ´çÁ¥»ê¿°È¸·Î
  • glucose tolerance test
    ´çºÎÇϰ˻ç
  • glucose-6-phosphatase
    Æ÷µµ´çÀ°ÀλêÈ­È¿¼Ò, ±Û·çÄÚ¿À½º-6-Æ÷½ºÆÄŸ¾ÆÁ¦
  • glucose-6-phosphate dehydrogenase
    6-ÀλêÆ÷µµ´çÅ»¼ö¼ÒÈ¿¼Ò
  • insulin-to-glucose ratio
    Àν¶¸°´ëÆ÷µµ´çºñ
  • liquid glucose
    ¾×üÆ÷µµ´ç
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´ç³»¼º°Ë»ç
  • urine glucose
    ¿ä´ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glucose
    Æ÷µµ´ç, ±Û·çÄÚ½º
  • urine glucose
    ¿ä´ç
  • glucose intolerance
    Æ÷µµ´ç¸ø°ßµõ(Áõ), ´çºÒ³»¼º
  • glucose tolerance test
    ´çºÎÇϰ˻ç
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • low fever
    ¹Ì¿­
  • low risk group
    ÀúÀ§Ç豺
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹é
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹é
  • low potency
    ÀúÈ¿´É, Àú¿ª°¡, ÀúÀáÀç·Â
  • low signal
    ¾àÇѽÅÈ£, Àú½ÅÈ£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood glucose
    Ç÷´ç
  • cortisone glucose tolerance test
    ÄÚ¸£Æ¼¼ÕÆ÷µµ´çºÎÇϽÃÇè
  • glucose lactate cycle
    ±Û·çÄÚ¿À½º¶ôÆ®»êȸ·Î
  • glucose dehydrogenase
    Æ÷µµ´çÅ»¼ö¼ÒÈ¿¼Ò
  • glucose storage disease
    ´çÃàÀûº´
  • glucose fermenter
    Æ÷µµ´ç¹ßÈ¿Åë
  • glucose fluctuation
    Æ÷µµ´çº¯µ¿
  • glucose
    Æ÷µµ´ç, ±Û·çÄÚ½º
  • glucose-6-phosphatase
    Æ÷µµ´çÀ°ÀλêÈ­È¿¼Ò, ±Û·çÄÚ¿À½º-6-Æ÷½ºÆÄŸ¾ÆÁ¦
  • glucose monitoring
    Æ÷µµ´ç°¨½Ã
  • glucose insulin tolerance test
    Æ÷µµ´çÀν¶¸°°ßµõ°Ë»ç
  • glucose tolerance test
    Æ÷µµ´ç°ßµõ°Ë»ç
  • liquid glucose
    ¾×üÆ÷µµ´ç
  • insulin-to-glucose ratio
    Àν¶¸°Æ÷µµ´çºñÀ²
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • POMC(pro-opio-melano-cortin)
    Àü¾ÆÆí¾ç¸á¶ó´ÑÀÚ±ØÈ£¸£¸ó
  • Castellani-Low symptom
    Ä«½ºÅÚ¶ó´Ï-·Î¿ìÁõ»ó.
  • LDL = low density lipoprotein
    Àú¹ÐµµÁö´Ü¹é(î¸ÚËÓøò·Ó±ÛÜ)
  • VLDL => very low density lipoprotein
    ÃÊÀú¹ÐµµÁö ´Ü¹éÁú
  • frequency deafness, low
    ÀúÁ֯ijó, ÀúÁÖÆÄ±Í¸ÔÀ½
  • hellp(hemolysis, elevated liver enzymes, low platelet),heliminths
    À±Ãæ(ëÌõù)
  • GOD= glucose oxidase
    Æ÷µµ´ç»êÈ­ È¿¼Ò.
  • GTT= glucose tolerance test
    ´çºÎÇÏ °Ë»ç.
  • Glucose
    ±Û·çÄÚ¿À½º
  • Glucose phosphatase
    Àλê(×òß«)±Û·çÄÚ¿À½º
  • Glucose tolerance
    ³»´ç·Â(Ò±ÓØÕô)
  • Glucose transporters
    ´çÀü´Þü(ÓØîîÓ¹ô÷)
  • Glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ¿À½º-6-Àλê(×òß«)Å»¼ö¼ÒÈ¿¼Ò(÷­â©áÈý£áÈ)
  • Glucose-galactose malabsorption syndrome
    ±Û·çÄÚ¿À½º-°¥¶ôÅ佺Èí¼öÀå¾ÖÁõÈıº(ýåâ¥î¡äôñøý¦ÏØ)
  • Sabouraud glucose agar [medium]
    »çºê·Î Æ÷µµ´çÇÑõ¹èÁö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • external occipital protuberance<³ª> pro tube r antia occipitalis externa
    ¿ÜÈĵÎÀ¶±â(èâý­ÔéëØÑÃ).
  • gradient echo technique magnetic susceptibility pro
    °æ»ç ¿¡ÄÚ¹ý ÀÚ±âÈ­À² ¾ç¼ºÀÚ ÀÌ¿Ï Áõ°­
  • peer review organization(PRO)
    µ¿·á½É»çÀ§¿øÈ¸.
  • blood glucose
    Ç÷´ç(úìÓØ).
  • chopped meat glucose broth
    Àú¹Î°í±â-Æ÷µµ´ç ¾×ü¹èÁö
  • cortisone glucose tolerance test =CGTT
    ÄÚ¸£Æ¼¼Õ Æ÷µµ´ç ºÎÇϽÃÇè(¡­øã Ô¬ÓØÝ¶ùÃãËúÐ).
  • d-Glucose ceramide
    d-Æ÷µµ´ç ¼¼¶ó¹Ìµå
  • diabetes mellitus,oral glucose tolerance test
    °æ±¸´çºÎÇÏ °Ë»ç(ÌèÏ¢ÓØÝ¶ùà ËþÞÛ)
  • glucose
    Æ÷µµ´ç.
  • glucose
    Æ÷µµ´ç(øãÔ¬ÓØ)
  • glucose
    ±Û·çÄÚ½º, Æ÷µµ´ç.
  • glucose
    Æ÷µµ´ç
  • glucose
    Æ÷µµ´ç
  • glucose 1 phosphate
    ±Û·çÄÚ¿À½º-1-Àλê.
  • glucose 3 phosphatase =G-3-P
    ±Û·çÄÚ¿À½º-3-Æ÷½ºÆÄŸÁ¦.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pro-
    ÇÁ·Î-
  • pro-ACTH-endorphin
    ÇÁ·Î-ACTH-¿£µµ¸£ÇÉ
  • adenosine diphosphate glucose
    ÀÌÀλê(ì£ìÝß«)¾Æµ¥³ë½Å ±Û·çÄÚ½º
  • ADP-glucose
    ADP-±Û·çÄÚ½º
  • glucose
    ±Û·çÄÚ½º
  • glucose-alanine cycle
    ±Û·çÄÚ½º-¾Ë¶ó´Ñ ȸ·Î(üÞÖØ)
  • glucose effect
    ±Û·çÄÚ½º È¿°ú(üùÍý)
  • glucose electrode
    ±Û·çÄÚ½º Àü±Ø(ï³Ð¿)
  • glucose-6-phosphatase
    ±Û·çÄÚ½º-6-Æ÷½ºÆÄÅ×À̽º
  • glucose-6-phosphate
    ±Û·çÄÚ½º-6-Àλê(×òß«)
  • glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ½º-6-Àλê(×òß«) µðÇÏÀ̵å·ÎÀú³×À̽º
  • glucose-6-phosphate dehydrogenase deficiency
    ±Û·çÄÚ½º-6-Àλê(×òß«) µðÇÏÀ̵å·ÎÀú³×À̽º °áÇÌ(ÌÀ
  • glucose-regulated protein
    ±Û·çÄÚ½º-Á¶Àý (ðàï½) ´Ü¹éÁú(Ó±ÛÜòõ)
  • glucose repression
    ±Û·çÄÚ½º ¾ïÁ¦(åäð¤)
  • glucose tolerance factor
    ±Û·çÄÚ½º ³»¼º ÀÎÀÚ(Ò±àõì×í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glucose
    Æ÷µµ´ç
  • glucose tolerance
    ³»´ç·Â
  • fast Low Angle Shot [=FLASH]
    °í¼ÓÀú°¢¿µ»óȹµæ
  • low attenuation
    ³·Àº °¨¾à
  • low back pain
    ¿äÅë
  • low echo area
    Àú¿¡ÄÚ±¸¿ª
  • low field MR scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • low intensity void in proton flow
    ¾ç¼ºÀÚÈ帧ÀÇ Àú°­µµ¼Ò½Ç
  • low pass filter
    ÀúÅë°ú¿©°ú±â
  • low signal
    Àú½ÅÈ£
  • low signal intensity
    Àú½ÅÈ£°­µµ
  • ultra low field MR scanner
    ÃÊÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PRO-PBP pro-platelet basic protein
LP labile peptide; labile protein; laboratory procedure; lactic peroxidase; lamina propria; laryngophar...
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
LF labile factor; lactoferrin; laryngofissure; Lassa fever; latex fixation; left foot; left forearm; le...
LFD lactose-free diet; large for date [fetus]; late fetal death; lateral facial dysplasia; least fatal d...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Pro-UK Pro-Urokinase
pro-NPY Pro-neuropeptide Y
pro-TRH Pro-thyrotrophin-releasing hormone
pro-CCK pro-cholecystokinin
pro-enk pro-enkephalin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pro
    Àü±¸
    ¾Õ, Àü¹æÀÇ ¶æÀ» ³ªÅ¸³»´Â Á¢µÎ¾î.
  • low biscuit stage µµÀç ÀÔÀÚ°¡ ¼­·Î ÀÀÁýµÇ³ª ´Ù°ø¼ºÀ̸ç, ºÎ¼­Áö±â ½¬¿î »óÅÂ.

    low blood pressure

    ÀúÇ÷¾Ð
    Ç÷¾Ð°è·Î Àü¿Ï µ¿¸ÆÀÇ Ç÷¾ÐÀ» ÃøÁ¤ÇÏ¿´À» ¶§ Ç÷¾ÐÀÌ Á¤»óº¸´Ù ³·Àº °æ¿ìÀÇ ÃÑĪ. Á¤»ó °ªÀº ¿¬·É, ¼º¿¡ µû¶ó ´Ù¸£Áö¸¸, ´ë°³ ÃÖ°í Ç÷¾ÐÀÌ 100 mmHg ÀÌÇÏÀ̸é ÀúÇ÷¾ÐÀ̶ó°í ÇÑ´Ù. ±×·¯³ª °íÇ÷¾ÐÁõÀÇ »ç¶÷ÀÌ ±Þ°ÝÈ÷ Ç÷¾ÐÀÌ ¶³¾îÁø °æ¿ì´Â Ç÷¾ÐÄ¡°¡ ºñ·Ï Á¤»ó ¹üÀ§¶ó ÇÒÁö¶óµµ ÀúÇ÷¾Ð Áõ¼¼¸¦ ÃÊ·¡ÇÏ´Â ¼ö°¡ ÀÖ´Ù. ÀúÇ÷¾ÐÀ» ÃÊ·¡ÇÏ´Â ÁúȯÀ¸·Î¼­´Â Å©°Ô ¸¸¼º Áö¼Ó¼º ÀúÇ÷¾ÐÁõ°ú ±â¸³¼º ÀúÇ÷¾Ð ¹× ¼îÅ©°¡ ÀÖ´Ù.¡¼¸¸¼º Áö¼Ó¼º ÀúÇ÷¾ÐÁõ¡½ °¢Á¾ÀÇ ½É Áúȯ
  • low-voltage low-amperage biphasic current
    ÀúÀü¾Ð ÀúÀü·ùÀÇ º¹Çü Àü·ù
  • low-voltage, low-amperage, biphasic current
    ÀúÀü¾Ð ÀúÀü·ùÀÇ º¹Çü Àü·ù
  • cortisone glucose tolerance test
    ÄÚ¸£Æ¼¼Õ Æ÷µµ´ç ºÎÇÏ ½ÃÇè
  • uridine diphosphate glucose
    ÀÌÀÎ»ê ¿ì¸®µò ±Û·çÄÚ½º
  • venous plasma blood glucose
    Á¤¸Æ Ç÷Àå Ç÷´çÄ¡, Á¤¸Æ Ç÷Àå Ç÷´ç
  • Castellani-Low symptom
    Ä«½ºÅÚ¶ó´Ï-·Î¿ì Áõ»ó
    ¼ö¸éº´ ȯÀÚ¿¡°Ô¼­ º¼ ¼ö ÀÖ´Â ¼³ ÁøÀü.
  • low
    ³·Àº, Àú
  • low birth weight
    ÀúüÁß Ãâ»ý
  • low carat gold alloy
    ÀúÄ«¶óÆ® ±Ý ÇÕ±Ý
    16Ä«¶óÆ® ÀÌÇÏÀÇ ±Ý ÇÕ±Ý. ³³Âø ÇÕ±ÝÀ» ¸»ÇÑ´Ù.
  • low copper amalgam
    Àú µ¿ ¾Æ¸»°¨
  • low frequency
    ÀúÁÖÆÄ
    Á֯ļö°¡ ³·Àº ÆÄ. Áï, ÀüÀÚ±âÆÄÀÇ Á֯ļö¿¡ ÀÇÇÑ ºÐ·ù·Î¼­, º¸Åë 10 kHz ÀÌÇϸ¦ ¸»ÇÑ´Ù. ¿Àµð¿À
  • low frequency therapeutic apparatus
    ÀúÁÖÆÄ Ä¡·á±â
  • low fusing porcelain
    Àú¿Â ¿ëÀ¶ µµÀç
    Ä¡°ú¿ë µµÀçÀÇ Á¾·ùÀε¥ 1600¡Æ¡­2000¢µ¿¡¼­ 󸮵Ǵ µµÀçÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ATP citrate (pro-3S)-lyase <enzyme> An enzyme that, in the presence of ATP and CoA, catalyses the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and orthophosphate. This reaction represents an important step in fatty acid biosynthesis.
Chemical name: ATP:citrate oxaloacetate-lyase ((pro-S)-CH2COO(-)--acetyl-CoA) (ATP-dephosphorylating)
Registry number: EC 4.1.3.8
Synonym: citrate cleavage enzyme.
(12 Dec 1998)
RNA, transfer, pro A transfer RNA which is specific for carrying proline to sites on the ribosomes in preparation for protein synthesis.
(12 Dec 1998)
citrate (pro-3S)-lyase <enzyme> Consists of two enzymes and an acyl carrier protein
Registry number: EC 4.1.3.6
Synonym: citrate lyase
(26 Jun 1999)
citrate (pro-3S)-lyase deacetylase <enzyme> Catalyses conversion of enzymatically active acetyl-s-citrate lyase (4.1.3.6) into inactive hs-form and acetate
Registry number: EC 3.1.2.-
Synonym: citrate lyase deacetylase
(26 Jun 1999)
citrate (pro-3S)-lyase ligase <enzyme> Deacetylcitrate lyase, acetate and ATP forms citrate lyase, AMP, pi
Registry number: EC 6.2.1.22
Synonym: citc gene product, acetate-sh-citrate lyase ligase, citrate lyase ligase
(26 Jun 1999)
Pro Symbol for proline or its radicals.
(05 Mar 2000)
pro- <prefix> Prefix (from both Greek and Latin) with many meanings including before, in front of, preceding, on behalf of, in place of, and the same as. Used as a word, pro of course means professional and, in medicine, it is short for prothrombin.
(12 Dec 1998)
pro-lactase-phlorizin hydrolase <chemical>
Synonym: pro-lph
(26 Jun 1999)
pro-ocytocin-neurophysin convertase <enzyme> Cleaves pro-ocytocin-neurophysin at the cooh-terminal side of arg 12 to release the bioactive peptide
Registry number: EC 3.4.99.-
Synonym: pro-ot-np convertase, pro-oxytocin-neurophysin convertase
(26 Jun 1999)
pro opimelanocortin <protein> Polyprotein produced by the anterior pituitary that is cleaved to yield adrenocorticotrophin, _, _ and _ melanocyte stimulating hormones, lipotropic hormones, _ endorphin and other fragments.
(18 Nov 1997)
pro-opiomelanocortin <chemical> A precursor protein, mw 30,000, synthesised mainly in the anterior pituitary gland but also found in the hypothalamus, brain, and several peripheral tissues. It incorporates the amino acid sequences of acth and beta-lipotropin. These two hormones, in turn, contain the biologically active peptides msh, corticotropin-like intermediate lobe peptide, alpha-lipotropin, endorphins, and methionine enkephalin.
Chemical name: Opiomelanocortin, pro-
(12 Dec 1998)
pro-oxidants Compounds or agents capable of generating toxic oxygen species.
Compare: antioxidant.
(05 Mar 2000)
pro re nata As the occasion arises; as necessary.
Acronym: prn
Origin: L.
(05 Mar 2000)
pro-transforming growth factor-alpha processing protease <enzyme> Converts membrane-bound protgf-alpha to soluble tgf-alpha; mw 84 kD
Registry number: EC 3.4.21.-
Synonym: protgf-alpha converting enzyme, protgfalpha processing protease
(26 Jun 1999)
X-Pro aminopeptidase <enzyme> Proline specific exopeptidase
Registry number: EC 3.4.11.9
Synonym: x-prolyl aminopeptidase, proline-specific exopeptidase, aminopeptidase p
(26 Jun 1999)
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 1 ÆäÀÌÁö: 1
  • SureStep Pro Low Glucose InVt - »õâ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glucose
    Æ÷µµ´ç
  • invt.
    inventory
  • pro
    ÇÁ·Î
  • pro-
    ´ë½Å
  • Pro. Station
    ¼ºº´ ¿¹¹æ½Ã¼³
  • per pro
    per procurationem
  • pro
    ÇÁ·Î;Àü¹®°¡;Á÷¾÷¼±¼ö;Á÷¾÷ÀûÀÎ;Á÷¾÷¼±¼öÀÇ;ÇÁ·ÎÀÇ
  • pro
    Âù¼ºÇÏ¿©(pro and con ÂùºÎ µÎ °¥·¡·Î);ÂùºÎ¾ç·Ð(pros and cons ÂùºÎ¾çÆù,ÂùºÎÀÇ ÀÌÀ¯)
  • pro
    ¸ÅÃáºÎ
  • pro number
    (¹ß¼ÛÀÇ) ´©Áø ¹øÈ£
  • pro patria
    Á¶±¹À» À§ÇÏ¿©
  • pro tanto
    ±× Á¤µµ±îÁö
  • pro tempore
    Àӽ÷Î;´çºÐ°£;ÀϽÃÀûÀ¸·Î
  • pro tempore
    ÀϽÃÀûÀ¸·Î;Àá½ÃÀûÀ¸·Î;Àӽ÷Î
  • pro-
    ...À» À§ÇÏ¿©
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á